Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC

Clinical trial NCT06810609 · RECRUITING

Trial details

NCT number: NCT06810609
Sponsor: University Hospital, Bonn
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Non-Small Cell Cancer (NSCLC)

Start date: 2025-04-20
Primary completion: 2029-12-31
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.